Literature DB >> 12646422

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis.

David R Linden1, Jing-Xian Chen, Michael D Gershon, Keith A Sharkey, Gary M Mawe.   

Abstract

5-HT released from enterochromaffin cells acts on enteric nerves to initiate motor reflexes. 5-HT's actions are terminated by a serotonin reuptake transporter (SERT). In this study, we tested the hypothesis that inflammation leads to altered mucosal 5-HT signaling. Colitis was induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS), and experiments were conducted on day 6. 5-HT content, number of 5-HT-immunoreactive cells, and the proportion of epithelial cells that were 5-HT-immunoreactive increased twofold in colitis. The amount of 5-HT released under basal and stimulated conditions was significantly increased in colitis. SERT inhibition increased the 5-HT concentration in media bathing-stimulated control tissue to a level comparable to that of the stimulated colitis tissue. mRNA encoding SERT and SERT immunoreactivity were reduced during inflammation. Slower propulsion and reduced sensitivity to 5-HT-receptor antagonism were observed in colitis. These data suggest that colitis alters 5-HT signaling by increasing 5-HT availability while decreasing 5-HT reuptake. Altered 5-HT availability may contribute to the dysmotility of inflammatory bowel disease, possibly due to desensitization of 5-HT receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646422     DOI: 10.1152/ajpgi.00488.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  98 in total

Review 1.  Is there a SERT-ain association with IBS?

Authors:  M Camilleri
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

3.  Enteroendocrine cells: neglected players in gastrointestinal disorders?

Authors:  Gordon W Moran; Fiona C Leslie; Scott E Levison; J Worthington; John T McLaughlin
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

4.  Gastrointestinal Motility Monitor (GIMM).

Authors:  Jill M Hoffman; Elice M Brooks; Gary M Mawe
Journal:  J Vis Exp       Date:  2010-12-01       Impact factor: 1.355

5.  Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.

Authors:  Sunila Mahavadi; Robert S Flynn; John R Grider; Li-Ya Qiao; Karnam S Murthy; Krystina B Hazelgrove; John F Kuemmerle
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

Review 6.  Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon.

Authors:  Gary M Mawe
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

7.  Real-time measurement of serotonin release and motility in guinea pig ileum.

Authors:  Paul P Bertrand
Journal:  J Physiol       Date:  2006-09-07       Impact factor: 5.182

8.  Gut-derived serotonin contributes to bone deficits in colitis.

Authors:  B Lavoie; J A Roberts; M M Haag; S N Spohn; K G Margolis; K A Sharkey; J B Lian; G M Mawe
Journal:  Pharmacol Res       Date:  2018-07-17       Impact factor: 7.658

9.  High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression.

Authors:  Xiaochun Bian; Bhavik Patel; Xiaoling Dai; James J Galligan; Greg Swain
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

10.  Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation.

Authors:  Meagan M Costedio; Matthew D Coates; Elice M Brooks; Lisa M Glass; Eric K Ganguly; Hagen Blaszyk; Allison L Ciolino; Michael J Wood; Doris Strader; Neil H Hyman; Peter L Moses; Gary M Mawe
Journal:  Am J Gastroenterol       Date:  2009-12-15       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.